Colectomy is a risk factor for venous thromboembolism in ulcerative colitis
AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those pat...
Gespeichert in:
Veröffentlicht in: | World journal of gastroenterology : WJG 2015-01, Vol.21 (4), p.1251-1260 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1260 |
---|---|
container_issue | 4 |
container_start_page | 1251 |
container_title | World journal of gastroenterology : WJG |
container_volume | 21 |
creator | Kaplan, Gilaad G Lim, Allen Seow, Cynthia H Moran, Gordon W Ghosh, Subrata Leung, Yvette Debruyn, Jennifer Nguyen, Geoffrey C Hubbard, James Panaccione, Remo |
description | AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy. |
doi_str_mv | 10.3748/wjg.v21.i4.1251 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4306170</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849534852485053</cqvip_id><sourcerecordid>1652430813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</originalsourceid><addsrcrecordid>eNpVkU1PGzEQhq2qqKTQc2-Vj71ssD3-2kslFEFbFakXOFuOmU0Mu2uwN6n49zhKiKilkaXxM--M5yXkK2dzMNJe_HtYzbeCz6Occ6H4BzITgreNsJJ9JDPOmGlaEOaUfC7lgTEBoMQnciqUhsq1M_JnkXoMUxpeaCzU0xzLI-18zWTa1djimDaFTuuchmXCGn0sA40j3fQBs5_iFmmoySmWc3LS-b7gl8N9Ru6ur24Xv5qbvz9_Ly5vmqAYTI0VwTMR2BIUoEGL1oLX950Gr7hGA1qh6bzxqJkwCMFqy02LILm3jDM4Iz_2uk-b5YD3Accp-9495Tj4_OKSj-7_lzGu3SptnQSmudkJfD8I5PS8wTK5IZaAfe9HrL91XCtRWcuhohd7NORUSsbu2IYzt7PAVQtctcBF6XYW1Ipv76c78m87rwAcJNdpXD3HcXVkWmZ3p1VMWtkqkLYOYhVTAK_D_ZN8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1652430813</pqid></control><display><type>article</type><title>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</title><source>MEDLINE</source><source>Baishideng "World Journal of" online journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Kaplan, Gilaad G ; Lim, Allen ; Seow, Cynthia H ; Moran, Gordon W ; Ghosh, Subrata ; Leung, Yvette ; Debruyn, Jennifer ; Nguyen, Geoffrey C ; Hubbard, James ; Panaccione, Remo</creator><creatorcontrib>Kaplan, Gilaad G ; Lim, Allen ; Seow, Cynthia H ; Moran, Gordon W ; Ghosh, Subrata ; Leung, Yvette ; Debruyn, Jennifer ; Nguyen, Geoffrey C ; Hubbard, James ; Panaccione, Remo</creatorcontrib><description>AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v21.i4.1251</identifier><identifier>PMID: 25632199</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Adolescent ; Adult ; Anticoagulants - therapeutic use ; bowel ; Colectomy - adverse effects ; Colitis, Ulcerative - complications ; Colitis, Ulcerative - diagnosis ; Colitis, Ulcerative - drug therapy ; Colitis, Ulcerative - surgery ; colitis;Dee ; diseases;Ulcerative ; Elective Surgical Procedures ; Emergencies ; Female ; Gastrointestinal Agents - adverse effects ; Gastrointestinal Agents - therapeutic use ; Heparin - therapeutic use ; Humans ; Inflammatory ; Logistic Models ; Male ; Middle Aged ; Multivariate Analysis ; Observational Study ; Odds Ratio ; Risk Factors ; Time Factors ; Treatment Outcome ; Venous Thromboembolism - etiology ; Venous Thromboembolism - prevention & control ; Young Adult</subject><ispartof>World journal of gastroenterology : WJG, 2015-01, Vol.21 (4), p.1251-1260</ispartof><rights>The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. 2015</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</citedby><cites>FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306170/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306170/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25632199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kaplan, Gilaad G</creatorcontrib><creatorcontrib>Lim, Allen</creatorcontrib><creatorcontrib>Seow, Cynthia H</creatorcontrib><creatorcontrib>Moran, Gordon W</creatorcontrib><creatorcontrib>Ghosh, Subrata</creatorcontrib><creatorcontrib>Leung, Yvette</creatorcontrib><creatorcontrib>Debruyn, Jennifer</creatorcontrib><creatorcontrib>Nguyen, Geoffrey C</creatorcontrib><creatorcontrib>Hubbard, James</creatorcontrib><creatorcontrib>Panaccione, Remo</creatorcontrib><title>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anticoagulants - therapeutic use</subject><subject>bowel</subject><subject>Colectomy - adverse effects</subject><subject>Colitis, Ulcerative - complications</subject><subject>Colitis, Ulcerative - diagnosis</subject><subject>Colitis, Ulcerative - drug therapy</subject><subject>Colitis, Ulcerative - surgery</subject><subject>colitis;Dee</subject><subject>diseases;Ulcerative</subject><subject>Elective Surgical Procedures</subject><subject>Emergencies</subject><subject>Female</subject><subject>Gastrointestinal Agents - adverse effects</subject><subject>Gastrointestinal Agents - therapeutic use</subject><subject>Heparin - therapeutic use</subject><subject>Humans</subject><subject>Inflammatory</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Observational Study</subject><subject>Odds Ratio</subject><subject>Risk Factors</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Venous Thromboembolism - etiology</subject><subject>Venous Thromboembolism - prevention & control</subject><subject>Young Adult</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1PGzEQhq2qqKTQc2-Vj71ssD3-2kslFEFbFakXOFuOmU0Mu2uwN6n49zhKiKilkaXxM--M5yXkK2dzMNJe_HtYzbeCz6Occ6H4BzITgreNsJJ9JDPOmGlaEOaUfC7lgTEBoMQnciqUhsq1M_JnkXoMUxpeaCzU0xzLI-18zWTa1djimDaFTuuchmXCGn0sA40j3fQBs5_iFmmoySmWc3LS-b7gl8N9Ru6ur24Xv5qbvz9_Ly5vmqAYTI0VwTMR2BIUoEGL1oLX950Gr7hGA1qh6bzxqJkwCMFqy02LILm3jDM4Iz_2uk-b5YD3Accp-9495Tj4_OKSj-7_lzGu3SptnQSmudkJfD8I5PS8wTK5IZaAfe9HrL91XCtRWcuhohd7NORUSsbu2IYzt7PAVQtctcBF6XYW1Ipv76c78m87rwAcJNdpXD3HcXVkWmZ3p1VMWtkqkLYOYhVTAK_D_ZN8</recordid><startdate>20150128</startdate><enddate>20150128</enddate><creator>Kaplan, Gilaad G</creator><creator>Lim, Allen</creator><creator>Seow, Cynthia H</creator><creator>Moran, Gordon W</creator><creator>Ghosh, Subrata</creator><creator>Leung, Yvette</creator><creator>Debruyn, Jennifer</creator><creator>Nguyen, Geoffrey C</creator><creator>Hubbard, James</creator><creator>Panaccione, Remo</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150128</creationdate><title>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</title><author>Kaplan, Gilaad G ; Lim, Allen ; Seow, Cynthia H ; Moran, Gordon W ; Ghosh, Subrata ; Leung, Yvette ; Debruyn, Jennifer ; Nguyen, Geoffrey C ; Hubbard, James ; Panaccione, Remo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c503t-82ca02c0b353e7e8e883a6df63a516e7365e7fa7ae6027e3c868179e341a80103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anticoagulants - therapeutic use</topic><topic>bowel</topic><topic>Colectomy - adverse effects</topic><topic>Colitis, Ulcerative - complications</topic><topic>Colitis, Ulcerative - diagnosis</topic><topic>Colitis, Ulcerative - drug therapy</topic><topic>Colitis, Ulcerative - surgery</topic><topic>colitis;Dee</topic><topic>diseases;Ulcerative</topic><topic>Elective Surgical Procedures</topic><topic>Emergencies</topic><topic>Female</topic><topic>Gastrointestinal Agents - adverse effects</topic><topic>Gastrointestinal Agents - therapeutic use</topic><topic>Heparin - therapeutic use</topic><topic>Humans</topic><topic>Inflammatory</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Observational Study</topic><topic>Odds Ratio</topic><topic>Risk Factors</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Venous Thromboembolism - etiology</topic><topic>Venous Thromboembolism - prevention & control</topic><topic>Young Adult</topic><toplevel>online_resources</toplevel><creatorcontrib>Kaplan, Gilaad G</creatorcontrib><creatorcontrib>Lim, Allen</creatorcontrib><creatorcontrib>Seow, Cynthia H</creatorcontrib><creatorcontrib>Moran, Gordon W</creatorcontrib><creatorcontrib>Ghosh, Subrata</creatorcontrib><creatorcontrib>Leung, Yvette</creatorcontrib><creatorcontrib>Debruyn, Jennifer</creatorcontrib><creatorcontrib>Nguyen, Geoffrey C</creatorcontrib><creatorcontrib>Hubbard, James</creatorcontrib><creatorcontrib>Panaccione, Remo</creatorcontrib><collection>中文科技期刊数据库</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>中文科技期刊数据库-7.0平台</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kaplan, Gilaad G</au><au>Lim, Allen</au><au>Seow, Cynthia H</au><au>Moran, Gordon W</au><au>Ghosh, Subrata</au><au>Leung, Yvette</au><au>Debruyn, Jennifer</au><au>Nguyen, Geoffrey C</au><au>Hubbard, James</au><au>Panaccione, Remo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Colectomy is a risk factor for venous thromboembolism in ulcerative colitis</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2015-01-28</date><risdate>2015</risdate><volume>21</volume><issue>4</issue><spage>1251</spage><epage>1260</epage><pages>1251-1260</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM: To compare venous thromboembolism(VTE) in hospitalized ulcerative colitis(UC) patients who respond to medical management to patients requiring colectomy. METHODS: Population-based surveillance from 1997 to 2009 was used to identify all adults admitted to hospital for a flare of UC and those patients who underwent colectomy. All medical charts were reviewed to confirm the diagnosis and extract clinically relevant information. UC patients were stratified by:(1) responsive to inpatient medical therapy(n = 382);(2) medically refractory requiring emergent colectomy(n = 309); and(3) elective colectomy(n = 329). The primary outcome was the development of VTE during hospitalization or within 6 mo of discharge. Heparin prophylaxis to prevent VTE was assessed. Logistic regression analysis determined the effect of disease course(i.e., responsive to medical therapy, medically refractory, and elective colectomy) on VTE after adjusting for confounders including age, sex, smoking, disease activity, comorbidities, extent of disease, and IBD medications(i.e., corticosteroids, mesalamine, azathioprine, and infliximab). Point estimates were presented as odds ratios(OR) with 95%CI.RESULTS: The prevalence of VTE among patients with UC who responded to medical therapy was 1.3% and only 16% of these patients received heparinprophylaxis. In contrast, VTE was higher among patients who underwent an emergent(8.7%) and elective(4.9%) colectomy, despite greater than 90% of patients receiving postoperative heparin prophylaxis. The most common site of VTE was intra-abdominal(45.8%) followed by lower extremity(19.6%). VTE was diagnosed after discharge from hospital in 16.7% of cases. Elective(adjusted OR = 3.69; 95%CI: 1.30-10.44) and emergent colectomy(adjusted OR = 5.28; 95%CI: 1.93-14.45) were significant risk factors for VTE as compared to medically responsive UC patients. Furthermore, the odds of a VTE significantly increased across time(adjusted OR = 1.10; 95%CI: 1.01-1.20). Age, sex, comorbidities, disease extent, disease activity, smoking, corticosteroids, mesalamine, azathioprine, and infliximab were not independently associated with the development of VTE. CONCLUSION: VTE was associated with colectomy, particularly, among UC patients who failed medical management. VTE prophylaxis may not be sufficient to prevent VTE in patients undergoing colectomy.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>25632199</pmid><doi>10.3748/wjg.v21.i4.1251</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2015-01, Vol.21 (4), p.1251-1260 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4306170 |
source | MEDLINE; Baishideng "World Journal of" online journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adolescent Adult Anticoagulants - therapeutic use bowel Colectomy - adverse effects Colitis, Ulcerative - complications Colitis, Ulcerative - diagnosis Colitis, Ulcerative - drug therapy Colitis, Ulcerative - surgery colitis Dee diseases Ulcerative Elective Surgical Procedures Emergencies Female Gastrointestinal Agents - adverse effects Gastrointestinal Agents - therapeutic use Heparin - therapeutic use Humans Inflammatory Logistic Models Male Middle Aged Multivariate Analysis Observational Study Odds Ratio Risk Factors Time Factors Treatment Outcome Venous Thromboembolism - etiology Venous Thromboembolism - prevention & control Young Adult |
title | Colectomy is a risk factor for venous thromboembolism in ulcerative colitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A13%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Colectomy%20is%20a%20risk%20factor%20for%20venous%20thromboembolism%20in%20ulcerative%20colitis&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Kaplan,%20Gilaad%20G&rft.date=2015-01-28&rft.volume=21&rft.issue=4&rft.spage=1251&rft.epage=1260&rft.pages=1251-1260&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v21.i4.1251&rft_dat=%3Cproquest_pubme%3E1652430813%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1652430813&rft_id=info:pmid/25632199&rft_cqvip_id=90888889504849534852485053&rfr_iscdi=true |